This review examines the potential of fasting-mimicking diets (FMDs) in preventing and
treating Alzheimer's disease (AD). FMDs are low-calorie diets that mimic the physiological …

Alzheimer's Disease (AD) remains a formidable challenge due to its complex pathology,
notably involving mitochondrial dysfunction and dysregulated microRNA (miRNA) signaling …

The most prevalent chronic neurodegenerative illness in the world is Alzheimer's disease
(AD). It results in mental symptoms including behavioral abnormalities and cognitive …

Aims To investigate whether insula network connectivity modulates the relationship between
apolipoprotein E (APOE) ε4 genotype, cerebrospinal fluid (CSF) biomarkers (Aβ, Tau, and …

The monoaminergic nuclei are thought to be some of the earliest sites of Alzheimer's
disease (AD) pathology in the brain, with tau-containing pretangles appearing in these …

Alzheimer's disease (AD) is an age-dependent neurodegenerative disorder and the most
common cause of cognitive decline. The alarming epidemiological features of Alzheimer's …

BACKGROUND Early discrimination and prediction of cognitive decline are crucial for the
study of neurodegenerative mechanisms and interventions to promote cognitive resiliency …

Introduction Agitation, psychosis, and apathy are prevalent and highly distressing
neuropsychiatric symptoms (NPS) of Alzheimer's disease (AD) that have been linked to …

The future of therapy for neurodegenerative diseases (NDs) relies on new strategies
targeting multiple pharmacological pathways. Our research led to obtaining the compound …

Background: Cognitive training holds potential as a non-pharmacological intervention to
decrease cognitive symptoms associated with Alzheimer's disease (AD), but more research …